Christopher Sims

Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.

Argonaut Manufacturing Services, Inc. engages in providing contract manufacturing in the life science and biotech arena. It offers products launch, scale-up & volume, decline and sunset services. The company was founded in 2016 and is headquartered in Carlsbad, CA.

Dynex Technologies, Inc. develops laboratory and clinical instruments. It focuses on research of microplate analysis. The firm products include, DSX four-plate system, SpectraMR scanning spectrophotometer, MLX luminometer, UltraWash Plus washer, MRW multi-buffer washer and Fluorolux HB microplate. The company was founded in 1952 and is headquartered in Chantilly, VA

Trinity Partners LLC engages in provision of financial advisory services. Its services include strategic planning, and tactical and operational planning. The firm?s practice areas include corporate strategy, pipeline and portfolio optimization, licensing and acquisitions, brand and launch planning, market analysis, and advanced analytics. The company was founded by John E. Corcoran in 1996 and is headquartered in Waltham, MA.

Emerging Therapy Solutions, Inc. operates predictive intelligence platform which outsourced management of cell and gene therapy treatments for health care payers. It offers pipeline analytics, medical services, contract placement, claims administration, and reporting. The company was founded by Dave J. McLean and is headquartered in Bloomington, MN.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Genometrix, Inc. performs commercial physical and biological research. The private company is based in The Woodlands, TX.

Part of Revvity, Inc., Sage Labs, Inc. is a company that provides animal research models and support services. The company is based in St. Louis, MO. Sage Labs was acquired by Horizon Discovery Group Ltd., part of Revvity, Inc. from December 24, 2020 on September 29, 2014 for $48.05 million.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX.

Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada.

Agena Bioscience, Inc. develops, manufactures and supplies genetic analysis systems and reagents. The firm’s system are mass spectrometry-based platform for genetic analysis, and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. The company was founded in 2014 and is headquartered in San Diego, CA.

BluePrint Research Group LLC operates as a marketing research consultancy. It serves the healthcare companies to promote global health and wellness. The company was founded by Glen Bergstein in 2008 and is headquartered in Princeton, NJ.

Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD.

IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal.

Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina.

Blue Mountain Capital Group LLC (Private Equity) (Blue Mountain Capital) is a private equity subsidiary of Assured Investment Management LLC founded in 2012 by Andrew Todd Feldstein. The firm is headquartered in New York.

Carterra, Inc. engages in provision of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. It offers Kinetics software, Epitope mapping, therapeutic areas, and antibody formats. The company was founded by James Smith and Josh Eckman in 2005 and is headquartered in Salt Lake City, UT.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Sound Point Luna LLC (SPL) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Andrew Feldstein and Stephen Siderow in 2003 and formerly known as BlueMountain Capital Management LLC and as Assured Investment Management LLC. In 2023, Sound Point Capital Management LP acquired the firm from Assured Guaranty Ltd. (NYSE: AGO). SPL provides investment advisory services to pooled investment vehicles that operate as private investment funds and collateralized loan obligations (CLOs).

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA.

Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC.

kSep Systems LLC provides automated single-use bioprocessing solutions to the clients in the areas of recombinant therapeutics, cell therapy and vaccines manufacturing. The company was founded by Sunil Mehta and Joseph T. McMahon in 2011 and is headquartered in Morrisville, NC.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA.

Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.